During the first year of OA-07, patients received a second injection of either LOR or placebo. The second year involved a ...

Upadacitinib 15 mg plus a 26-week GC taper outperformed placebo in combination with a 52-week GC taper for the treatment of ...

The 'eFficAcy and Safety of cerTolizumab pegol – 4 Weekly dosAge in RheumatoiD arthritis' (FAST4WARD) trial was a 24-week randomized double-blind placebo-controlled multicenter study conducted ...

Additionally, the Arthritis Foundation hosts the Rheumatoid Arthritis Connect Group, inviting people living with the condition to engage with others who have shared experiences. This group also ...

Weight reduction has been shown to alleviate symptoms of osteoarthritis of the knee, including pain. The effect of glucagon-like peptide-1 receptor agonists on outcomes in knee osteoarthritis ...

Biologic response modifiers presently approved in the USA for use in various rheumatic inflammatory diseases include three TNF inhibitors (etanercept, infliximab and adalimumab), a B-cell-directed ...

Novartis previously revealed that Fabhalta yielded 35.1% proteinuria reduction compared to placebo on top of supportive care at the trial’s six-month mark. Both Apellis’ and Novartis’ drugs ...

Weather changes, such as changes in temperature, humidity, and air pressure, can sometimes worsen arthritis symptoms. Learn more about how you can manage symptoms. Arthritis is a complex joint ...

In these studies, there were 83.1% of patients in the obinutuzumab group and 63.4% in the rituximab group who achieved MRD negativity by bone marrow testing. In the study, researchers used ...

Osteoarthritis need not be the end of the world — or a stellar tennis career. After years of pain, three-time Grand Slam tennis champion Andy Murray had surgery to 'resurface' his hip joint that ...